Prokidney (PROK) Net Income towards Common Stockholders (2021 - 2026)

Prokidney (PROK) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$42.6 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 12.3% year-over-year to -$42.6 million in Q1 2026; TTM through Mar 2026 was -$124.1 million, a 25.21% increase from a year earlier, with the FY2025 full-year figure at -$69.0 million, down 12.75% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$42.6 million, down from -$8.7 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for PROK reached as high as -$8.7 million in Q4 2025 and fell as low as -$67.5 million in Q1 2022.
• Historically, Net Income towards Common Stockholders has averaged -$35.2 million across 5 years, with a median of -$36.9 million in 2023.
• Across the five-year window, Net Income towards Common Stockholders tumbled 415505.63% in 2022 and soared 82.08% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$14.4 million in 2022, then plunged by 50.86% to -$21.7 million in 2023, then slumped by 123.18% to -$48.5 million in 2024, then surged by 82.08% to -$8.7 million in 2025, then slumped by 390.69% to -$42.6 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$42.6 million in Q1 2026, -$8.7 million in Q4 2025, and -$35.8 million in Q3 2025.